163 related articles for article (PubMed ID: 16282495)
41. Avian sarcoma and leukosis virus-receptor interactions: from classical genetics to novel insights into virus-cell membrane fusion.
Barnard RJ; Elleder D; Young JA
Virology; 2006 Jan; 344(1):25-9. PubMed ID: 16364732
[TBL] [Abstract][Full Text] [Related]
42. Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection.
Rong L; Edinger A; Bates P
J Virol; 1997 May; 71(5):3458-65. PubMed ID: 9094617
[TBL] [Abstract][Full Text] [Related]
43. Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor.
Balliet JW; Berson J; D'Cruz CM; Huang J; Crane J; Gilbert JM; Bates P
J Virol; 1999 Apr; 73(4):3054-61. PubMed ID: 10074155
[TBL] [Abstract][Full Text] [Related]
44. Close linkage of genes encoding receptors for subgroups A and C of avian sarcoma/leucosis virus on chicken chromosome 28.
Elleder D; Plachý J; Hejnar J; Geryk J; Svoboda J
Anim Genet; 2004 Jun; 35(3):176-81. PubMed ID: 15147387
[TBL] [Abstract][Full Text] [Related]
45. Reverse Engineering Provides Insights on the Evolution of Subgroups A to E Avian Sarcoma and Leukosis Virus Receptor Specificity.
Federspiel MJ
Viruses; 2019 May; 11(6):. PubMed ID: 31151254
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of avian retroviral host range extension.
Rainey GJ; Natonson A; Maxfield LF; Coffin JM
J Virol; 2003 Jun; 77(12):6709-19. PubMed ID: 12767991
[TBL] [Abstract][Full Text] [Related]
47. Effects of lipid rafts on dynamics of retroviral entry and trafficking: Quantitative analysis.
Lim KI; Narayan S; Young JA; Yin J
Biotechnol Bioeng; 2004 Jun; 86(6):650-60. PubMed ID: 15137076
[TBL] [Abstract][Full Text] [Related]
48. The central proline of an internal viral fusion peptide serves two important roles.
Delos SE; Gilbert JM; White JM
J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
[TBL] [Abstract][Full Text] [Related]
49. Using the RCAS-TVA system to model human cancer in mice.
Ahronian LG; Lewis BC
Cold Spring Harb Protoc; 2014 Nov; 2014(11):1128-35. PubMed ID: 25368315
[TBL] [Abstract][Full Text] [Related]
50. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.
Damico R; Rong L; Bates P
J Virol; 1999 Apr; 73(4):3087-94. PubMed ID: 10074159
[TBL] [Abstract][Full Text] [Related]
51. Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.
Balliet JW; Gendron K; Bates P
J Virol; 2000 Apr; 74(8):3731-9. PubMed ID: 10729148
[TBL] [Abstract][Full Text] [Related]
52. Efficient subgroup C avian sarcoma and leukosis virus receptor activity requires the IgV domain of the Tvc receptor and proper display on the cell membrane.
Munguia A; Federspiel MJ
J Virol; 2008 Nov; 82(22):11419-28. PubMed ID: 18768966
[TBL] [Abstract][Full Text] [Related]
53. Avian sarcoma leukosis virus receptor-envelope system for simultaneous dissection of multiple neural circuits in mammalian brain.
Matsuyama M; Ohashi Y; Tsubota T; Yaguchi M; Kato S; Kobayashi K; Miyashita Y
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):E2947-56. PubMed ID: 25991858
[TBL] [Abstract][Full Text] [Related]
54. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.
Snitkovsky S; Niederman TM; Carter BS; Mulligan RC; Young JA
J Virol; 2000 Oct; 74(20):9540-5. PubMed ID: 11000224
[TBL] [Abstract][Full Text] [Related]
55. Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.
Barnard RJ; Narayan S; Dornadula G; Miller MD; Young JA
J Virol; 2004 Oct; 78(19):10433-41. PubMed ID: 15367609
[TBL] [Abstract][Full Text] [Related]
56. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein.
Snitkovsky S; Young JA
Virology; 2002 Jan; 292(1):150-5. PubMed ID: 11878917
[TBL] [Abstract][Full Text] [Related]
57. Conversion of a human low-density lipoprotein receptor ligandbinding repeat to a virus receptor: identification of residues important for ligand specificity.
Rong L; Gendron K; Bates P
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8467-72. PubMed ID: 9671701
[TBL] [Abstract][Full Text] [Related]
58. A single-amino-acid substitution in the TvbS1 receptor results in decreased susceptibility to infection by avian sarcoma and leukosis virus subgroups B and D and resistance to infection by subgroup E in vitro and in vivo.
Reinisová M; Senigl F; Yin X; Plachy J; Geryk J; Elleder D; Svoboda J; Federspiel MJ; Hejnar J
J Virol; 2008 Mar; 82(5):2097-105. PubMed ID: 18094190
[TBL] [Abstract][Full Text] [Related]
59. The solution structure of the viral binding domain of Tva, the cellular receptor for subgroup A avian leukosis and sarcoma virus.
Tonelli M; Peters RJ; James TL; Agard DA
FEBS Lett; 2001 Dec; 509(2):161-8. PubMed ID: 11768384
[TBL] [Abstract][Full Text] [Related]
60. Identification of novel viral receptors with cell line expressing viral receptor-binding protein.
Mei M; Ye J; Qin A; Wang L; Hu X; Qian K; Shao H
Sci Rep; 2015 Jan; 5():7935. PubMed ID: 25604889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
